Supply of Pirfenidone 267 mg and 801 mg (film-coated) tablets

Auto-translated from Dutch

Original title: LEVEREN VAN PIRFENIDONE 267 mg en 801 mg (filmomhulde) tabletten

UZ Leuven

Published: Jun 30, 2026

Updated: Jun 30, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Belgium, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before September 14, 2026.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Dutch

This tender, sourced from Belgium via TED, is for the supply of Pirfenidone medication in film-coated tablet form, specifically in 267 mg and 801 mg dosages. The contracting authority is seeking a reliable pharmaceutical supplier to provide this essential medicine. Pirfenidone is commonly prescribed for the treatment of idiopathic pulmonary fibrosis (IPF). Key requirements for this type of tender typically include demonstrated compliance with Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP), ensuring the quality, safety, and efficacy of the pharmaceutical products. Bidders must be licensed pharmaceutical manufacturers or distributors authorised to supply medicines within the European Union. The tender will likely require detailed product specifications, including batch traceability, expiry date management, packaging compliance, and potentially specific storage and transportation conditions. Evidence of prior experience in supplying similar pharmaceutical products, along with robust quality management systems and regulatory compliance documentation, will be critical for bidders. The contract is likely to focus on security of supply and timely delivery to meet patient needs.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on June 30, 2026. Last refreshed today. Original language: Dutch. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About UZ Leuven

UZ Leuven has issued 45 procurement notices on BidsFactory, including 7 currently open and 15 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and General Supplies & Services. All notices are published for Belgium. Notices are distributed via Belgium e-Procurement and TED - Tenders Electronic Daily (EU). Most recent publication: June 30, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Belgium. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is September 14, 2026. You have 76 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by UZ Leuven in Belgium. The authority is responsible for evaluating bids, awarding the contract, and managing performance.